IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pear Therapeutics Inc

CUSIP: 704723105 | 94 institutional holders

Quarters

Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2024

Roble, Belko & Company, Inc4,502
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Roble, Belko & Company, Inc
4,502$00.0%ETFVery LowSewickley, PA2024-04-11